Ding L, Xu Y, Liu S, Bi Y, Xu Y. Hemoglobin A1c and diagnosis of diabetes. J Diabetes. 2018;10(5):365–72.

Article  CAS  PubMed  Google Scholar 

Gomez-Peralta F, Choudhary P, Cosson E, Irace C, Rami-Merhar B, Seibold A. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin. Diabetes Obes Metab. 2022;24(4):599–608.

Article  CAS  PubMed  Google Scholar 

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44(8):968–83.

Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial–revisited. Diabetes. 2008;57(4):995–1001.

Article  CAS  PubMed  Google Scholar 

Dandona P. Minimizing Glycemic fluctuations in patients with type 2 diabetes: approaches and importance. Diabetes Technol Ther. 2017;19(9):498–506.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovatchev B, Cobelli C. Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care. 2016;39(4):502–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cobelli C, Facchinetti A. Yet another glucose variability index: time for a paradigm change? Diabetes Technol Ther. 2018;20(1):1–3.

Article  PubMed  Google Scholar 

Monnier L, Colette C, Owens DR. The application of simple metrics in the assessment of glycaemic variability. Diabetes Metab. 2018;44(4):313–9.

Article  CAS  PubMed  Google Scholar 

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M. International Consensus on Use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631–40.

Article  PubMed  PubMed Central  Google Scholar 

Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36(8):2249–55.

Article  CAS  PubMed  Google Scholar 

Akirov A, Amitai O, Masri-Iraqi H, Diker-Cohen T, Shochat T, Eizenberg Y, Shimon I. Predictors of hypoglycemia in hospitalized patients with diabetes mellitus. Intern Emerg Med. 2018;13(3):343–50.

Article  PubMed  Google Scholar 

Braithwaite SS. Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence. Curr Diab Rep. 2013;13(1):138–54.

Article  CAS  PubMed  Google Scholar 

Bergenstal RM, Mullen DM, Strock E, Johnson ML, Xi MX. Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes. J Diabetes Complications. 2022;36(3):108106.

Article  CAS  PubMed  Google Scholar 

Monnier L, Wojtusciszyn A, Colette C, Owens D. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther. 2011;13(8):813–8.

Article  CAS  PubMed  Google Scholar 

Kauffmann RM, Hayes RM, Buske BD, Norris PR, Campion TR Jr., Dortch M, Jenkins JM, Collier BR, May AK. Increasing blood glucose variability heralds hypoglycemia in the critically ill. J Surg Res. 2011;170(2):257–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bajaj HS, Venn K, Ye C, Patrick A, Kalra S, Khandwala H, Aslam N, Twum-Barima D, Aronson R. Lowest glucose variability and hypoglycemia are observed with the combination of a GLP-1 receptor agonist and basal insulin (VARIATION Study). Diabetes Care. 2017;40(2):194–200.

Article  CAS  PubMed  Google Scholar 

Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681–7.

Article  CAS  PubMed  Google Scholar 

Akirov A, Diker-Cohen T, Masri-Iraqi H, Shimon I. High glucose variability increases mortality risk in hospitalized patients. J Clin Endocrinol Metab. 2017;102(7):2230–41.

Article  PubMed  Google Scholar 

Mendez CE, Mok KT, Ata A, Tanenberg RJ, Calles-Escandon J, Umpierrez GE. Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care. 2013;36(12):4091–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Timmons JG, Cunningham SG, Sainsbury CA, Jones GC. Inpatient Glycemic variability and long-term mortality in hospitalized patients with type 2 diabetes. J Diabetes Complications. 2017;31(2):479–82.

Article  PubMed  Google Scholar 

Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36(11):3008–13.

Article  CAS  PubMed  Google Scholar 

Olsen MT, Dungu AM, Klarskov CK, Jensen AK, Lindegaard B, Kristensen PL. Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community-acquired pneumonia. BMC Pulm Med. 2022;22(1):83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Julla JB, Jacquemier P, Fagherazzi G, Vidal-Trecan T, Juddoo V, Jaziri A, Mersel H, Venteclef N, Roussel R, Massin P, Couturier A, Gautier JF, Riveline JP. Is the consensual threshold for defining high glucose variability implementable in clinical practice? Diabetes Care. 2021;44(7):1722–5.

Article  CAS  PubMed  Google Scholar 

Mo Y, Ma X, Lu J, Shen Y, Wang Y, Zhang L, Lu W, Zhu W, Bao Y, Zhou J. Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes. J Diabetes Investig. 2021;12(6):1025–34.

Article  CAS  PubMed  Google Scholar 

Rodbard D. Clinical interpretation of indices of quality of glycemic control and glycemic variability. Postgrad Med. 2011;123(4):107–18.

Article  PubMed  Google Scholar 

Monnier L, Colette C, Owens D. Below which threshold of glycemic variability is there a minimal risk of hypoglycemia in people with type 2 diabetes? Diabetes Technol Ther. 2022;24(6):453–4.

Article  PubMed  Google Scholar 

Donahue SR, Turner KC, Patel S. Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes. Clin Pharmacokinet. 2002;41(15):1301–9.

Article  CAS  PubMed  Google Scholar 

Chinese Expert Consensus on Medical Nutrition Therapy for Overweight/Obesity. Chin J Diabetes Mellitus. 2016;10(10):451–5.

Google Scholar 

Shaefer C, Reid T, Vlajnic A, Zhou R, DiGenio A. FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C. Endocr Pract. 2015;21(12):1323–32.

Article  PubMed  Google Scholar 

Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract. 2007;77(2):280–5.

Article  CAS  PubMed  Google Scholar 

Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of Glycemic Indices (Hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and Diabetic complications. J Diabetes Res. 2020;2020:7489795.

Article  PubMed  PubMed Central  Google Scholar 

Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):119.

Article  PubMed  PubMed Central  Google Scholar 

Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care. 2009;32(3):381–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

PJ. Gycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus. Mayo Clin Proc. 2001;76(6):609–18.

Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349–54.

Article  CAS  PubMed  Google Scholar 

Ohara M, Fukui T, Ouchi M, Watanabe K, Suzuki T, Yamamoto S, Yamamoto T, Hayashi T, Oba K, Hirano T. Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes. Diabetes Res Clin Pract. 2016;122:62–70.

Article  CAS  PubMed  Google Scholar 

Andersen A, Jørgensen PG, Bagger JI, Baldassarre MPA, Christensen MB, Pedersen-Bjergaard U, Lindhardt TB, Gislason G, Knop FK, Vilsbøll T. Acute changes in plasma glucose increases left ventricular systolic function in insulin-treated patients with type 2 diabetes and controls. Diabetes Obes Metab. 2022;24(6):1123–31.

Article